We found that scale expression of RGD-p21Ras-scFv greatly stopped the development of xenograft tumors while ensuring a certain safety profile, specifically targeting xenograft tumors and reducing the proliferation of tumor cells. This evidence concerns the gene HRAS and neoplasm.